Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Value of Geriatric Assessments in Predicting Treatment Tolerance and Overall Survival in Older Patients With Breast Cancer.

NCT03640117 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT03640117
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03640117 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Value of Geriatric Assessments in Predicting Treatment Tolerance and Overall Survival in Older Patients With Breast Cancer.
Lead sponsor
Peking University People's Hospital
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2018
Completion date
May 1, 2025
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aging, breast cancer, chemotherapeutic toxicity, survival